Skip to main content
. Author manuscript; available in PMC: 2018 Feb 22.
Published in final edited form as: Inflammation. 2014 Oct;37(5):1401–1412. doi: 10.1007/s10753-014-9864-7

Fig. 1.

Fig. 1

Effects of L-4F and apoA-I on LPS-mediated production of inflammatory cytokines in whole human blood. L-4F or apoA-I (40 μg/ml) reduces plasma levels of TNF-α (A) and IL-6 (B) in the healthy whole human blood incubated with LPS (1 μg/ml) for 3 h in vitro (n=4/group). *P<0.05 vs. saline-treated LPS, #P<0.05 vs. control groups.